Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-25-048617·Crumly Richard K.
Schedule 13G ownership disclosure
BIOAFFINITY TECHNOLOGIES INC
Common Stock, par value $0.007 per share · CUSIP: 09076W109
Event date: 2025-05-07
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Richard K. Crumly
Shares: 3,213,777.00 · Class: 11.2%
- ADAMAS LLC
Shares: 400,027.00 · Class: 0.1%
- BMUS PARTNERS LLC
Shares: 10,000.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-048617
- Form type
- SCHEDULE 13G
- Filer
- Crumly Richard K.
- CIK
- CIK 1783794
- Filed
- May 14, 2025
- Reporting period
- May 07, 2025
- Description
- Schedule 13G beneficial ownership